US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Matthews Emerging Markets Equity Active ETF

30.93

-0.0683-0.22%

Post-market: 30.88-0.0566-0.18%16:05 EDT

Volume:618.00

Turnover:19.09K

Market Cap:37.74M

PE:- -

High:30.93

Open:30.92

Low:30.88

Close:31.00

Loading ...

Overview Company News Filings

Memphasys Says Diagnostic Device Processes Nearly 100 Samples in Less Than an Hour

MT Newswires Live

OMC Global Raises Safety and Customer Service Standards with Samsara

Closing Bell: ASX inches into positive territory on diminished tariffs fears

Memphasys achieves key milestone with clinical validation of Felix fertility device

Monday’s HotCopper Trends: Opthea strife, Errawarra jumps on acquisitions, Memphasys best-in-class trial results | March 21, 2025

The Market Herald

Memphasys tech: Trial results prove it lifts the guys’ game in IVF

The Market Herald

Agora Launches Conversational AI Toolkit for IoT Devices

Here's Why Memphasys (ASX:MEM) Can Afford Some Debt

Simply Wall St.

Lunch Wrap: WiseTech drags down ASX as execs bail, stock tanks 24pc

Memphasys Completes Felix System Clinical Trial, Shares Rise Past 14%

MT Newswires Live

Memphasys Says Publication of Study Demonstrates Oxidative Stress Profiling System Potential

MT Newswires Live

Health Check: ProMedicus lands $33m deal; Memphasy’s RoXsta antioxidant profiling shows potential

Publication highlights strengths of Memphasys’ antioxidant profiling system

The Market Herald

Memphasys to Start Utilization Testing of Reproductive Biotechnology Product in China

MT Newswires Live

ASX Small-Cap Stocks to Watch

MT Newswires Live

Sperm tech player Memphasys ships unit to Dubai – but can the stock attract liquidity?

The Market Herald

Memphasys Ltd Reports Positive AGM Outcomes

ASX Lunch Wrap: Curve ball thrown as new bank levy bites; Alderan jumps on US copper hit

ASX Small-Cap Stocks to Watch

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/MEM/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MEM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MEM\",,,,,undefined,":{"symbol":"MEM","market":"US","secType":"STK","nameCN":"Matthews Emerging Markets Equity Active ETF","latestPrice":30.9316,"timestamp":1747425600000,"preClose":30.9999,"halted":0,"volume":618,"hourTrading":{"tag":"盘后","latestPrice":30.875,"preClose":30.9316,"latestTime":"16:05 EDT","volume":2,"amount":61.8632,"timestamp":1747425915750},"delay":0,"floatShares":1220000,"shares":1220000,"eps":0,"marketStatus":"Market Closed","change":-0.0683,"latestTime":"05-16 16:00:00 EDT","open":30.92,"high":30.9316,"low":30.875,"amount":19088.9162,"amplitude":0.001826,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1747641600000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":30.9999,"sharesOutstanding":1220000,"nav":31.058,"aum":37890168.02,"dividendRate":0.073064,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":30.875,"preClose":30.9316,"latestTime":"16:05 EDT","volume":2,"amount":61.8632,"timestamp":1747425915750},"volumeRatio":0.364602},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MEM\",,,,,undefined,":{"symbol":"MEM","floatShares":1220000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.364602,"shares":1220000,"dividePrice":2.26,"high":30.9316,"amplitude":0.001826,"preClose":30.9999,"low":30.875,"week52Low":26.07,"pbRate":"--","week52High":36.15,"institutionHeld":0,"latestPrice":30.9316,"eps":0,"divideRate":0.073064,"volume":618,"delay":0,"ttmEps":0,"open":30.92,"prevYearClose":28.93,"prevWeekClose":30.06,"prevMonthClose":29.3824,"prevQuarterClose":29.31,"fiveDayClose":30.06,"twentyDayClose":28.4519,"sixtyDayClose":30.5316},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MEM\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2534486401","title":"Memphasys Says Diagnostic Device Processes Nearly 100 Samples in Less Than an Hour","url":"https://stock-news.laohu8.com/highlight/detail?id=2534486401","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534486401?lang=en_us&edition=fundamental","pubTime":"2025-05-09 11:45","pubTimestamp":1746762332,"startTime":"0","endTime":"0","summary":"Memphasys  confirmed the RoXsta Mega Cell High-Throughput Assay device was capable of simultaneously processing 96 samples in less than an hour during recent trials, according to a Thursday filing with the Australian bourse.The diagnostic device has been developed for rapid and high-capacity testing of reactive oxygen species levels in biological fluids, the filing said.The device has been utilized in various studies, including assessing oxidative stress in cattle and assessing antioxidant levels in professional footballers, per the filing.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MEM","BK7048","MEM.AU"],"gpt_icon":0},{"id":"2528273487","title":"OMC Global Raises Safety and Customer Service Standards with Samsara","url":"https://stock-news.laohu8.com/highlight/detail?id=2528273487","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528273487?lang=en_us&edition=fundamental","pubTime":"2025-04-17 01:30","pubTimestamp":1744824600,"startTime":"0","endTime":"0","summary":"The luxury transport provider saw a 15% reduction in insurance premiums after just three months with Samsara’s Connected Operations Platform.LONDON, April 16, 2025----Oxford-based luxury private-hire vehicle company OMC Global has raised its safety and customer service standards across its fleet of vehicles by implementing advanced AI and fleet management solutions from Samsara Inc.  , the pioneer of the Connected Operations Platform.Philip van der Wilt, SVP and GM EMEA at Samsara, comments: \"By providing OMC Global with access to real-time data, advanced insights, and the tools to drive operational efficiency, we’ve helped the team to set new industry standards for luxury transport. This relationship truly demonstrates how digital transformation can unlock value for our customers.\"","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/omc-global-raises-safety-customer-173000386.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585","BK4588","LU0772969993.USD","LU1481011911.USD","LU0321505868.SGD","LU1509826696.USD","BK4009","MEM","BK4613","LU0731783048.USD","LU1481011671.HKD","LU1599440770.SGD","OMC","IOT","LU0731783394.SGD","LU0321505439.SGD","LU0742537680.HKD","BK4023"],"gpt_icon":0},{"id":"2522885840","title":"Closing Bell: ASX inches into positive territory on diminished tariffs fears","url":"https://stock-news.laohu8.com/highlight/detail?id=2522885840","media":"Stockheads","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522885840?lang=en_us&edition=fundamental","pubTime":"2025-03-24 15:07","pubTimestamp":1742800075,"startTime":"0","endTime":"0","summary":"The ASX 200 pushed into the green on a choppy Monday. Fears around Trump’s tariffs trade war somewhat quelled. The index was propped up by discretionary and financials sectors, as well as a couple of big miners","market":"nz","thumbnail":"https://stockhead.com.au/wp-content/uploads/2025/03/GettyImages-1406773049-1200x675-1-640x360.jpg","type":0,"news_type":0,"thumbnails":["https://stockhead.com.au/wp-content/uploads/2025/03/GettyImages-1406773049-1200x675-1-640x360.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stockhead.com.au/news/closing-bell-asx-inches-into-positive-territory-on-diminished-tariffs-fears/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockheads_stock","symbols":["MEM"],"gpt_icon":0},{"id":"2521568759","title":"Memphasys achieves key milestone with clinical validation of Felix fertility device","url":"https://stock-news.laohu8.com/highlight/detail?id=2521568759","media":"Small Caps","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521568759?lang=en_us&edition=fundamental","pubTime":"2025-03-24 11:49","pubTimestamp":1742788164,"startTime":"0","endTime":"0","summary":"Memphasys  has published positive data from a pivotal clinical trial of its Felix electrophoresis-based sperm separation device for use in assisted reproduction.The trial validated the ability of the Felix device to meet and exceed industry benchmarks and found it to be non-inferior to the “swim-up” technique but statistically superior to DGC , the world’s most commonly used sperm preparation method.The company conducted the trial, which confirmed the device to have best-in-class performance in sperm selection for human fertility treatments, in partnership with Perth-based clinic Monash IVF Australia.Felix also demonstrated a positive primary endpoint of improved embryo utilisation compared with swim-up and DGC.Specifically, the number of embryos utilised divided by the total number of embryos created, a benchmark of assisted reproduction cycle success.Memphasys chief executive officer David Ali said the Felix trial was the most rigorous study ever conducted for a sperm separation devi","market":"nz","thumbnail":"https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2025/03/Memphasys-ASX-MEM-Felix-Clinical-Trial-Confirms-Best-in-Class-Performance.jpg","type":0,"news_type":0,"thumbnails":["https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2025/03/Memphasys-ASX-MEM-Felix-Clinical-Trial-Confirms-Best-in-Class-Performance.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://smallcaps.com.au/memphasys-clinical-validation-felix-fertility-device/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"smallcap_stock","symbols":["MEM.AU","MEM","BK7048"],"gpt_icon":0},{"id":"2521734542","title":"Monday’s HotCopper Trends: Opthea strife, Errawarra jumps on acquisitions, Memphasys best-in-class trial results | March 21, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2521734542","media":"The Market Herald","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521734542?lang=en_us&edition=fundamental","pubTime":"2025-03-24 10:13","pubTimestamp":1742782380,"startTime":"0","endTime":"0","summary":"The ASX has been trading flat at around 7,928 points.Discretionary has been the best performing sector today, up 1%, followed by Financials, up 0.66%, and Utilities, up 0.5%.Staples has been the worst performing, down 1%, followed by Materials, down 0.9%, and Industrials, down 0.8%.Opthea  has been the most watched on HotCopper forums today and is in a trading halt. Its COAST Phase 3 trial failed to meet primary endpoint of mean change in best corrected visual acuity from baseline to Week 52. The company is now considering the overall impact of the negative trial result heading into the year.Also trending: Errawarra Resources , which has entered binding agreements to acquire 70% of the historical Elizabeth Hill Silver Project, 70% of the silver rights to the Pinderi Hills Project tenement package, and 70% of the ownership of three tenements surrounding the silver project.Rounding out the most discussed has been Memphasys , which unveiled the successful unblinding and data analysis of i","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketonline.com.au/mondays-hotcopper-trends-opthea-strife-errawarra-jumps-on-acquisitions-memphasys-best-in-class-trial-results-march-21-2025-2025-03-24/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["BK7067","MEM.AU","BK7508","MEM","ERW.AU","OPT.AU","OPT","BK7095","BK7048"],"gpt_icon":0},{"id":"2521102733","title":"Memphasys tech: Trial results prove it lifts the guys’ game in IVF","url":"https://stock-news.laohu8.com/highlight/detail?id=2521102733","media":"The Market Herald","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521102733?lang=en_us&edition=fundamental","pubTime":"2025-03-24 07:07","pubTimestamp":1742771220,"startTime":"0","endTime":"0","summary":"Reproductive technology developed by Memphasys  is proving to be a gamechanger in addressing the men’s side of infertility – which is now understood to cause at least half of all conception issues.The company’s Felix System has successfully completed its Phase III clinical trial, proving it works faster than traditional methods, without adverse effects, and with scientists preferring it over the most widely used traditional IVF technologies.Memphasys reached its primary endpoint comparing its Embryo Utilisation Rateagainst existing Density Gradient Centrifugation  and Swim-Up IVF techniques.The trial has proven Felix is as good as the Swim-Up technique and “superior” to the world’s most used DGC method. And, Felix has other benefits in relation to both existing methods, which I’ll run through shortly.Memphasys partnered with Monash IVF Group , another Australian reproductive and fertility services company, for the trials.It’s in this male reproduction side where Memphasys is positioned","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketonline.com.au/memphasys-tech-trial-results-prove-it-lifts-the-guys-game-in-ivf-2025-03-24/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["BK7508","UAE","ART.AU","MEM","BK7113","BK7002","BK7048","MVF.AU","MEM.AU"],"gpt_icon":0},{"id":"2518221441","title":"Agora Launches Conversational AI Toolkit for IoT Devices","url":"https://stock-news.laohu8.com/highlight/detail?id=2518221441","media":"CNW Group","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518221441?lang=en_us&edition=fundamental","pubTime":"2025-03-10 21:00","pubTimestamp":1741611600,"startTime":"0","endTime":"0","summary":"New partnerships with Beken and Robopoet showcase the future of interactive toys and connected devices. SANTA CLARA, Calif., March 10, 2025 /CNW/ -- Agora, Inc. , a global leader in real-time engagement solutions, is expanding into AI-powered robotics and interactive toys with its new ConvoAI Device Kit. This breakthrough solution—developed in partnership with chip-maker Beken—delivers an all-in-one toolkit that empowers developers and manufacturers to create intelligent, voice-driven interactions for next-generation conversational AI in smart devices.The ConvoAI Device Kit integrates Beken's high-performance AI chip modules with Agora's Conversational AI technology, enabling ultra-low latency voice interactions, intelligent dialogue processing, and seamless real-time communication. This innovative solution is designed to make AI-driven devices, toys, and robots more interactive, intuitive, and emotionally responsive.\"Conversational AI is key to making robots and AI-driven toys truly i","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/agora-launches-conversational-ai-toolkit-130000365.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["API","MEM","BK4503","BK4551","BK4023","BK4535"],"gpt_icon":0},{"id":"2516572818","title":"Here's Why Memphasys (ASX:MEM) Can Afford Some Debt","url":"https://stock-news.laohu8.com/highlight/detail?id=2516572818","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516572818?lang=en_us&edition=fundamental","pubTime":"2025-03-03 07:33","pubTimestamp":1740958437,"startTime":"0","endTime":"0","summary":"Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-mem/memphasys-shares/news/heres-why-memphasys-asxmem-can-afford-some-debt","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7048","MEM","MEM.AU","EBIT"],"gpt_icon":0},{"id":"2513797692","title":"Lunch Wrap: WiseTech drags down ASX as execs bail, stock tanks 24pc","url":"https://stock-news.laohu8.com/highlight/detail?id=2513797692","media":"Stockheads","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513797692?lang=en_us&edition=fundamental","pubTime":"2025-02-24 11:21","pubTimestamp":1740367293,"startTime":"0","endTime":"0","summary":"ASX starts the week slow WiseTech hit hard after four execs quit US markets dive as Trump tariffs weigh heavy The ASX 200 index has bounced back from earlier losses this morning – where it was down by","market":"us","thumbnail":"https://stockhead.com.au/wp-content/uploads/2025/02/WiseTech-hit-hard-after-four-execs-quit.-Picture-via-Getty-Images-640x360.jpg","type":0,"news_type":0,"thumbnails":["https://stockhead.com.au/wp-content/uploads/2025/02/WiseTech-hit-hard-after-four-execs-quit.-Picture-via-Getty-Images-640x360.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stockhead.com.au/news/lunch-wrap-wisetech-drags-down-asx-as-execs-bail-stock-tanks-24pc/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockheads_stock","symbols":["MEM"],"gpt_icon":0},{"id":"2510878158","title":"Memphasys Completes Felix System Clinical Trial, Shares Rise Past 14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510878158","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510878158?lang=en_us&edition=fundamental","pubTime":"2025-02-11 15:00","pubTimestamp":1739257236,"startTime":"0","endTime":"0","summary":"Memphasys  completed a clinical trial of its advanced sperm selection technology, Felix System, for assisted reproductive technology procedures, according to a Tuesday Australian bourse filing.It achieved the last patient visit in the trial, with all required patient visits, including pregnancy outcomes completed, the filing said.Data lock is anticipated in around two weeks, following a final data clean-up, management, and source verification phase.It will use the trial data as part of its ongoing CE Mark submission to advanced commercialization activities in Europe. Regulatory approvals in Australia and India are expected to follow soon after.The firm's shares rose past 14% on market close on Tuesday.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XKO.AU","XJO.AU","MEM","MEM.AU","XAO.AU","BK7048"],"gpt_icon":0},{"id":"2503984990","title":"Memphasys Says Publication of Study Demonstrates Oxidative Stress Profiling System Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2503984990","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503984990?lang=en_us&edition=fundamental","pubTime":"2025-01-16 10:44","pubTimestamp":1736995457,"startTime":"0","endTime":"0","summary":"Memphasys   said the publication of a study in the \"Antioxidants\" journal reinforces the commercial potential as well as the scientific credibility of its RoXsta platform to identify oxidative stress in human and animal samples, according to a Thursday Australian bourse filing.RoXsta is a proprietary antioxidant diagnostic platform for identifying oxidative stress-related deficiencies, and the study supports its ability to diagnose oxidative stress through analysis of biological fluids, the filing added.The RoXsta system has potential for male infertility treatments as well as disease management in conditions such as neurodegenerative diseases, cardiovascular disorders, and cancer, the filing said.It is also exploring its potential for the optimization of livestock productivity by mitigating oxidative stress.Oxidative stress is linked to infertility, cardiovascular disease, neurodegenerative disorders, cancer, and other conditions, the filing said.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MEM","BK7048","MEM.AU"],"gpt_icon":0},{"id":"2503607940","title":"Health Check: ProMedicus lands $33m deal; Memphasy’s RoXsta antioxidant profiling shows potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2503607940","media":"Stockheads","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503607940?lang=en_us&edition=fundamental","pubTime":"2025-01-16 09:17","pubTimestamp":1736990249,"startTime":"0","endTime":"0","summary":"Pro Medicus signs $33m deal with University of Kentucky. Memphasys’ RoXsta system advances antioxidant profiling potential","market":"hk","thumbnail":"https://stockhead.com.au/wp-content/uploads/2025/01/Memphasys-showcases-potential-of-RoXsta.-Picture-via-Getty-Images-640x360.jpg","type":0,"news_type":0,"thumbnails":["https://stockhead.com.au/wp-content/uploads/2025/01/Memphasys-showcases-potential-of-RoXsta.-Picture-via-Getty-Images-640x360.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stockhead.com.au/health/health-check-promedicus-lands-33m-deal-memphasys-roxsta-antioxidant-profiling-shows-potential/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockheads_stock","symbols":["MEM"],"gpt_icon":0},{"id":"2503604638","title":"Publication highlights strengths of Memphasys’ antioxidant profiling system","url":"https://stock-news.laohu8.com/highlight/detail?id=2503604638","media":"The Market Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503604638?lang=en_us&edition=fundamental","pubTime":"2025-01-16 07:28","pubTimestamp":1736983680,"startTime":"0","endTime":"0","summary":"Memphasys Ltd  has seen a boost to its proprietary antioxidant profiling system RoXsta through the publication of a recent manuscript that emphasises its commercial potential and scientific credibility.The publication, ‘A Comparative Analysis of the Antioxidant Profiles Generated by the RoXsta System for Diverse Biological Fluids,’ appeared in the prestigious journal Antioxidants and was co-authored by Laureate Professor John Aitken, Memphasys’ scientific director, and a team of researchers from the University of Newcastle.Managing director and CEO of Memphasys David Ali said the manuscript was a testament to RoXsta’s transformative capabilities.“Its diagnostic power not only reinforces Memphasys’ leadership in reproductive health but also positions us for broader market opportunities in livestock and clinical applications.Join the discussion:See what HotCopperusers are saying aboutMemphasys Ltd and be part of the conversations that move the markets.The material provided in this articl","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketonline.com.au/publication-highlights-strengths-of-memphasys-antioxidant-profiling-system-2025-01-16/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["MEM","BK7048","MEM.AU"],"gpt_icon":0},{"id":"2501426779","title":"Memphasys to Start Utilization Testing of Reproductive Biotechnology Product in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2501426779","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501426779?lang=en_us&edition=fundamental","pubTime":"2025-01-06 09:07","pubTimestamp":1736125631,"startTime":"0","endTime":"0","summary":"Memphasys  will start in vitro utilization testing of its Felix System in China as part of an agreement with Hong Kong-based biotech company Heranova Lifesciences HK, according to a Monday filing with the Australian bourse.Heranova will conduct testing at Sichuan Jinxin Xinan Women & Children Hospital in Chengdu to assess the usability of the system in routine and challenging in vitro fertilization cases using 50 patient cases, with the company supplying 50 Felix cartridges and one console, the filing said.The testing will assess the biological performance and health economic benefits of the system, according to the filing.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MEM","MEM.AU","BK7048"],"gpt_icon":0},{"id":"2490181219","title":"ASX Small-Cap Stocks to Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2490181219","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490181219?lang=en_us&edition=fundamental","pubTime":"2024-12-12 07:38","pubTimestamp":1733960321,"startTime":"0","endTime":"0","summary":"Investors are likely to keep an eye on the following small-cap stocks listed on the Australian Securities Exchange.Memphasys (ASX:MEM)The biotechnology company signed a letter of intent with Heranova ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IXU.AU","SRR.AU","BK7095","MEM","VEN.AU","BK7048","BK7104","BK7016","MEM.AU","PAT.AU","GLL.AU","BK7142"],"gpt_icon":0},{"id":"2489705141","title":"Sperm tech player Memphasys ships unit to Dubai – but can the stock attract liquidity?","url":"https://stock-news.laohu8.com/highlight/detail?id=2489705141","media":"The Market Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489705141?lang=en_us&edition=fundamental","pubTime":"2024-12-05 10:42","pubTimestamp":1733366520,"startTime":"0","endTime":"0","summary":"Biotech nanocap Memphasys  has sent a demo unit of its Felix sperm separator system to a hospital in Dubai, United Arab Emirates.In short, to make artificial insemination work, you need to separate the actual sperm from semen, which is otherwise just another version of something the human body is pretty good at making: Mucus. . The Felix device uses the same process used to separate DNA and protein molecules from other mediums – electrophoresis.It works like this: Individual sperms happen to carry a negative charge due to their chemistry – going into why is incredibly boring – and so by placing the semen in a conductive salted gel, adding some membranes, and playing around with electricity thereafter, you eventually end up with isolated sperm.The material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research and consult with a certified financial advisor before making any investment decision","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketonline.com.au/sperm-tech-player-memphasys-ships-unit-to-dubai-but-can-the-stock-attract-liquidity-2024-12-05/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["BK7048","MEM.AU","MEM"],"gpt_icon":0},{"id":"2485240337","title":"Memphasys Ltd Reports Positive AGM Outcomes","url":"https://stock-news.laohu8.com/highlight/detail?id=2485240337","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485240337?lang=en_us&edition=fundamental","pubTime":"2024-11-22 10:37","pubTimestamp":1732243046,"startTime":"0","endTime":"0","summary":"Memphasys Ltd (AU:MEM) has released an update. Memphasys Limited (ASX: MEM), a leader in reproductive biotechnology, announced the successful outco...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/memphasys-ltd-reports-positive-agm-outcomes?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/memphasys-ltd-reports-positive-agm-outcomes?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AGM","MEM","BK4229","BK4195"],"gpt_icon":0},{"id":"2484159356","title":"ASX Lunch Wrap: Curve ball thrown as new bank levy bites; Alderan jumps on US copper hit","url":"https://stock-news.laohu8.com/highlight/detail?id=2484159356","media":"Stockheads","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484159356?lang=en_us&edition=fundamental","pubTime":"2024-11-18 11:28","pubTimestamp":1731900537,"startTime":"0","endTime":"0","summary":"ASX opens lower as US rate expectations weigh NAB faces lawsuit, banks hit by new levy Alderan jumps on copper drilling hit in the US The ASX has turned around to a positive gain at the halfway mark o","market":"hk","thumbnail":"https://stockhead.com.au/wp-content/uploads/2024/11/Alderan-jumps-on-copper-drilling-hit-in-the-US.-Picture-via-Getty-Images-640x360.jpg","type":0,"news_type":0,"thumbnails":["https://stockhead.com.au/wp-content/uploads/2024/11/Alderan-jumps-on-copper-drilling-hit-in-the-US.-Picture-via-Getty-Images-640x360.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stockhead.com.au/news/asx-lunch-wrap-asx-thrown-curve-ball-as-new-bank-levy-bites-alderan-jumps-on-us-copper-hit/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockheads_stock","symbols":["MEM"],"gpt_icon":0},{"id":"2484688926","title":"ASX Small-Cap Stocks to Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2484688926","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484688926?lang=en_us&edition=fundamental","pubTime":"2024-11-18 07:47","pubTimestamp":1731887264,"startTime":"0","endTime":"0","summary":"Investors are likely to keep an eye on the following small-cap stocks listed on the Australian Securities Exchange.Memphasys The biotechnology company reached 95% of the target patient pool in its clinical trial for the Felix system, a sperm separation technology for assisted reproductive treatments, with recruitment expected to finish by year-end.Many Peaks Minerals Many Peaks Minerals named Francis Harper independent non-executive chairman, effective Dec. 1, succeeding Executive Chairman Travis Schwertfeger, who will transition to the managing director role.Spectur The technology company's subsidiary, 3 Crowns Technologies, secured a three-year contract with New South Wales Government agency Transport for NSW to provide cameras and analytic services, with a minimum value of AU$787,428 and optional extensions of up to nine years.GBM Resources GBM Resources' White Dam Gold project in South Australia shipped roughly 500 ounces of gold in the current quarter to date, valued at about AU$2","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MPK.AU","GBZ.AU","GMN.AU","XAO.AU","BK7084","MEM.AU","BK7048","BK7095","BK7104","SP3.AU","XJO.AU","MEM","XKO.AU"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":19,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MEM\",params:#limit:5,,,undefined,":[{"date":"2024-12-18","symbol":"MEM","amount":2.26077,"announcedDate":"2024-12-17","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-18","defaultRemindTime":1734532200000,"name":"Matthews Emerging Markets Equity Active ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-23","payableDate":"2024-12-18","currency":"USD","dateTimestamp":1734498000000,"payDate":"2024-12-23"},{"date":"2023-12-14","symbol":"MEM","amount":0.00305,"announcedDate":"2023-12-13","type":"dividend","market":"US","newRecordDate":"2023-12-15","defaultRemindTime":1702564200000,"name":"Matthews Emerging Markets Equity Active ETF","recordDate":"2023-12-21","payableDate":"2023-12-15","currency":"USD","dateTimestamp":1702530000000,"payDate":"2023-12-21"},{"market":"US","date":"2022-12-14","symbol":"MEM","amount":0.14045,"defaultRemindTime":1671028200000,"name":"Matthews Emerging Markets Equity Active ETF","recordDate":"2022-12-21","payableDate":"2022-12-15","currency":"USD","type":"dividend","dateTimestamp":1670994000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MEM\",market:\"US\",,,undefined,":[{"executeDate":"2022-12-14","recordDate":"2022-12-15","paymentDate":"2022-12-21","value":0.14045,"currency":"USD"},{"executeDate":"2023-12-14","recordDate":"2023-12-15","paymentDate":"2023-12-21","value":0.00305,"currency":"USD"},{"executeDate":"2024-12-18","recordDate":"2024-12-18","paymentDate":"2024-12-23","value":2.26077,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MEM\",market:\"US\",delay:false,,,undefined,":{}}}